SMOX and myeloid sarcoma: Given the critical role of oxidative stress and inflammation in the pathogenesis of MS and EAE, we have formerly demonstrated that SMOX inhibition could offer neuroprotective effects in EAE pathology [42] and other ocular diseases [37,42,43].